# Sofosbuvir/Ledipasvir for Hepatitis C Genotype 1-6 in Patients With Transfusion-Dependent Thalassemia: An Open Label Trial

> **NCT03032666** · PHASE4 · COMPLETED · sponsor: **Ala'a Sharara** · enrollment: 7 (actual)

## Conditions studied

- Thalassemia
- Hepatitis C

## Interventions

- **DRUG:** sofosbuvir/velpatasvir

## Key facts

- **NCT ID:** NCT03032666
- **Lead sponsor:** Ala'a Sharara
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-05-01
- **Primary completion:** 2018-08-06
- **Final completion:** 2018-08-06
- **Target enrollment:** 7 (ACTUAL)
- **Last updated:** 2018-10-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03032666

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03032666, "Sofosbuvir/Ledipasvir for Hepatitis C Genotype 1-6 in Patients With Transfusion-Dependent Thalassemia: An Open Label Trial". Retrieved via AI Analytics 2026-07-28 from https://api.ai-analytics.org/clinical/NCT03032666. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*